Cellectis S.A.
CLLS
$1.26
$0.0352.87%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 76.24% | -21.12% | -70.85% | -96.06% | 242.28% |
| Total Other Revenue | -13.20% | -19.85% | -10.83% | 28.78% | 19.62% |
| Total Revenue | 46.95% | -20.70% | -52.39% | -64.26% | 602.48% |
| Cost of Revenue | -75.83% | -84.22% | -87.96% | -90.58% | 102.64% |
| Gross Profit | 50.51% | -17.87% | -50.34% | -62.31% | 11.86% |
| SG&A Expenses | 36.03% | 8.83% | 3.40% | -3.89% | 28.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 83.05% | 99.51% | 112.29% | 121.71% | -79.56% |
| Total Operating Expenses | 16.90% | 2.92% | -2.25% | -8.58% | 20.08% |
| Operating Income | -6.80% | -10.26% | -13.07% | -7.40% | 15.21% |
| Income Before Tax | -6.39% | 6.91% | -7.09% | -40.26% | -38.30% |
| Income Tax Expenses | -212.64% | -199.42% | 24.14% | 325.29% | -- |
| Earnings from Continuing Operations | -5.41% | 7.52% | -7.11% | -40.51% | -38.93% |
| Earnings from Discontinued Operations | 232.31% | 26,912.86% | 334.29% | 277.00% | 144.82% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -78.19% | -83.31% | -7.64% | 18.76% | -1.14% |
| Net Income | 0.62% | 17.61% | 36.33% | 3.78% | 17.49% |
| EBIT | -6.80% | -10.26% | -13.07% | -7.40% | 15.21% |
| EBITDA | -7.86% | -12.28% | -19.14% | -11.93% | 18.88% |
| EPS Basic | 35.77% | 41.51% | 50.22% | 24.31% | 26.04% |
| Normalized Basic EPS | 31.33% | 19.94% | 14.65% | -11.35% | -45.60% |
| EPS Diluted | 22.28% | 30.27% | 40.01% | 24.45% | 26.07% |
| Normalized Diluted EPS | 30.00% | 18.63% | 13.36% | -11.35% | -45.60% |
| Average Basic Shares Outstanding | 57.00% | 42.50% | 32.20% | 25.34% | 15.10% |
| Average Diluted Shares Outstanding | 72.02% | 58.28% | 48.86% | 25.34% | 15.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
